Market Segment: HealthCare Specialties Niche ETFs
Evaluating Niche ETFs
Overview
Franklin Genomic Advancements ETF
Provides access to companies benefiting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine.
Exchange Listing | BATS |
Niche ETF – Category | Innovation |
Niche ETF – Market Segment | Healthcare Specialties |
Inception Date | 2/25/20 |
Number of Holdings | 24 |
Rebalancing Schedule | Actively Managed |
Weighting Method | Cap Weighted |
Management Style | Active |
Tactic | Smart Beta |
Factors | Multi-factor |
Additional information regarding the ETF‘s performance, pricing, NAV, trading volume, AUM, exposures and fee structure can be located by clicking on the PERFORMANCE button at the top of the page for this fund.
Franklin Genomic Advancements ETF
This ETF is actively managed. There is no index associated.
Disclosure
NicheETFs.com does not promote, issuer or endorse the content of this information or guarantee it’s accuracy for the purposes of making any investment decisions. It is solely for general information purposes and should not be relied upon when making investment decisions without consulting an investment, financial or tax professional. NicheETFs.com makes no representations about the suitability of the information, products or services presented, nor of those of any issuer links. Past performance is not indicative of future results.
Share This Niche ETF, Choose a Platform!
Advertisement Space